By concentrating on the illness's root induce at the molecular stage, peptide therapies give a far more qualified strategy, reducing harm to healthy cells and decreasing Unwanted effects—a big breakthrough in ailment administration and procedure. Clinical trials and preclinical studies are highlighted, showing the efficacy of peptide vaccines